Shuai Chen

1.6k total citations
63 papers, 1.2k citations indexed

About

Shuai Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shuai Chen has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 24 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Shuai Chen's work include RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (13 papers) and interferon and immune responses (6 papers). Shuai Chen is often cited by papers focused on RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (13 papers) and interferon and immune responses (6 papers). Shuai Chen collaborates with scholars based in China, United States and South Korea. Shuai Chen's co-authors include Wenlin Huang, Chunjie Sheng, Chen Yao, Jiangxue Wu, Ziyang Wang, Ranyi Liu, Rong Geng, Jiaxin Lin, Xin Tan and Zhizhong Pan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shuai Chen

59 papers receiving 1.2k citations

Peers

Countries citing papers authored by Shuai Chen

Since Specialization

Citations

This map shows the geographic impact of Shuai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Chen more than expected).

Fields of papers citing papers by Shuai Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Chen. The network helps show where Shuai Chen may publish in the future.

Co-authorship network of co-authors of Shuai Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Chen. A scholar is included among the top collaborators of Shuai Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Chen. Shuai Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation	eLife	Qi Zeng, Yao Chen et al.	0
2	Mendelian randomization analysis to identify potential drug targets for osteoarthritis	PLoS ONE	Chenqi Lu, Shuai Chen et al.	1
3	Interleukin 8 exacerbates age-related hearing loss through regulating perivascular-resident macrophage-like melanocytes viability and the permeability of the endothelial cells	International Immunopharmacology	Shuai Chen, Yi Zhou et al.	0
4	Causal relationship of genetically predicted gut microbiota with thyroid cancer: a bidirectional two-sample mendelian randomization study	Frontiers in Endocrinology	Xiaohe Sun, Shuai Chen et al.	4
5	SHISA3 Reprograms Tumor‐Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy	Advanced Science	Shimeng Zhang, Bingbing Yu et al.	13
6	Cyclophilin J limits linear ubiquitin signaling and controls colorectal cancer progression	Journal of Biological Chemistry	Chunjie Sheng, Chen Yao et al.	2
7	ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation	eLife	Qi Zeng, Yao Chen et al.	1
8	CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway	Scientific Reports	Shuai Chen, Ran Wei et al.	5
9	Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency	JAMA Network Open	Brian L. Sprague, Shuai Chen et al.	1
10	Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma	Frontiers in Oncology	Zhixin Liu, Shuai Chen et al.	2
11	Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry	Frontiers in Immunology	Weijie Ma, Bridget McLaughlin et al.	8
12	Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma	Journal of Translational Medicine	Ziyang Wang, Chunjie Sheng et al.	22
13	Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells	Advanced Science	Ziyang Wang, Chunjie Sheng et al.	62
14	Preoperative differentiation of serous cystic neoplasms from mucin-producing pancreatic cystic neoplasms using a CT-based radiomics nomogram	Abdominal Radiology	Shuai Chen, Shuai Ren et al.	16
15	ARHGEF19 regulates MAPK/ERK signaling and promotes the progression of small cell lung cancer	Biochemical and Biophysical Research Communications	Ziyang Wang, Chunjie Sheng et al.	9
16	CALML6 Controls TAK1 Ubiquitination and Confers Protection against Acute Inflammation	The Journal of Immunology	Chunjie Sheng, Ziyang Wang et al.	11
17	RNAi Screening Identifies that TEX10 Promotes the Proliferation of Colorectal Cancer Cells by Increasing NF‐κB Activation	Advanced Science	Ziyang Wang, Chunjie Sheng et al.	20
18	Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China	OncoTargets and Therapy	Yanlong Yang, Yongchun Zhou et al.	30
19	Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study	BMC Cancer	Qiu-Yan Chen, Lin-Quan Tang et al.	22
20	[Over-expression of phospholipase D3 inhibits Akt phosphorylation in C2C12 myoblasts].	PubMed	Junlin Zhang, Shuai Chen et al.	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact